Searching for smart, safe news you can TRUST?Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.Catch up on coronavirus stories and special reports, curated by Mike Allen everydayCatch up on coronavirus stories and special reports, curated by Mike Allen everydayDenver news in your inboxCatch up on the most important stories affecting your hometown with Axios DenverDes Moines news in your inboxCatch up on the most important stories affecting your hometown with Axios Des MoinesMinneapolis-St. Paul news in your inboxCatch up on the most important stories affecting your hometown with Axios Twin CitiesTampa Bay news in your inboxCatch up on the most important stories affecting your hometown with Axios Tampa BayCharlotte news in your inboxCatch up on the most important stories affecting your hometown with Axios CharlottePhoto: Mario Tama via GettyModerna’s coronavirus vaccine will provide immunity from the disease for at least one year, the biotech company said Monday per Reuters.Why it matters: Moderna’s vaccine is one of two now authorized for emergency use in the U.S., as coronavirus cases surge past 22.5 million nationally and 90.8 million globally.The big picture: Moderna expects to deliver around 600 million to 1 billion doses in 2021.The U.S. has purchased a total of 200 million doses from Moderna.The company has signed agreements with several other countries including Japan, Canada and Israel, boosting hope as the number of global cases nears 91 million.The United Kingdom and the EU’s European Medicines Agency approved the vaccine this week.Yes, but: The World Health Organization cautioned on Monday that herd immunity is unlikely this year despite the vaccine rollout in countries around the world.
Original Source